真人做爰48姿势视图片|少妇真人直播免费视频|日本真人做爰A片|真人裸体做爰视频|真人与拘做爰视频免费观看|真人与拘做受免费视频一

補(bǔ)體成分3a(C3a)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法)

ELISA Kit for Complement Component 3a (C3a)

  • 補(bǔ)體成分3a(C3a)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) 產(chǎn)品包裝(模擬)
  • 補(bǔ)體成分3a(C3a)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) 產(chǎn)品包裝(模擬)
  • 補(bǔ)體成分3a(C3a)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) 實(shí)驗(yàn)結(jié)果圖
  • SEA387Hu.jpg 標(biāo)準(zhǔn)曲線圖
  • Certificate 通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

特異性

本試劑盒用于檢測補(bǔ)體成分3a(C3a),經(jīng)檢測與其它相似物質(zhì)無明顯交叉反應(yīng)。
由于受到技術(shù)及樣本來源的限制,不可能完成對所有相關(guān)或相似物質(zhì)交叉反應(yīng)檢測,因此本試劑盒有可能與未經(jīng)檢測的其它物質(zhì)有交叉反應(yīng)。

回收率

分別于定值血清及血漿樣本中加入一定量的補(bǔ)體成分3a(C3a)(加標(biāo)樣品),重復(fù)測定并計(jì)算其均值,回收率為測定值與理論值的比率。

樣本 回收率范圍(%) 平均回收率(%)
serum(n=5) 89-103 92
EDTA plasma(n=5) 99-105 102
heparin plasma(n=5) 97-105 101

精密度

精密度用樣品測定值的變異系數(shù)CV表示。CV(%) = SD/mean×100
批內(nèi)差:取同批次試劑盒對低、中、高值定值樣本進(jìn)行定量檢測,每份樣本連續(xù)測定20 次,分別計(jì)算不同濃度樣本的平均值及SD值。
批間差:選取3個(gè)不同批次的試劑盒分別對低、中、高值定值樣本進(jìn)行定量測定,每個(gè)樣本使用同一試劑盒重復(fù)測定8次,分別計(jì)算不同濃度樣本的平均值及SD值。
批內(nèi)差: CV<10%
批間差: CV<12%

線性

在定值血清及血漿樣本內(nèi)加入適量的補(bǔ)體成分3a(C3a),并倍比稀釋成1:2,1:4,1:8,1:16的待測樣本,線性范圍即為稀釋后樣本中補(bǔ)體成分3a(C3a)含量的測定值與理論值的比率。

樣本 1:2 1:4 1:8 1:16
serum(n=5) 89-101% 79-97% 90-101% 80-102%
EDTA plasma(n=5) 95-102% 90-98% 85-99% 80-101%
heparin plasma(n=5) 85-104% 91-98% 94-104% 84-102%

穩(wěn)定性

經(jīng)測定,試劑盒在有效期內(nèi)按推薦溫度保存,其活性降低率小于5%。
為減小外部因素對試劑盒破壞前后檢測值的影響,實(shí)驗(yàn)室的環(huán)境條件需盡量保持一致,尤其是實(shí)驗(yàn)室內(nèi)溫度、濕度及溫育條件。其次由同一實(shí)驗(yàn)員來進(jìn)行操作可減少人為誤差。

實(shí)驗(yàn)流程

1. 實(shí)驗(yàn)前標(biāo)準(zhǔn)品、試劑及樣本的準(zhǔn)備;
2. 加樣(標(biāo)準(zhǔn)品及樣本)100µL,37°C孵育1小時(shí);
3. 吸棄,加檢測溶液A100µL,37°C孵育1小時(shí);
4. 洗板3次;
5. 加檢測溶液B100µL,37°C孵育30分鐘;
6. 洗板5次;
7. 加TMB底物90µL,37°C孵育10-20分鐘;
8. 加終止液50µL,立即450nm讀數(shù)。

實(shí)驗(yàn)原理

將補(bǔ)體成分3a(C3a)抗體包被于96孔微孔板中,制成固相載體,向微孔中分別加入標(biāo)準(zhǔn)品或標(biāo)本,其中的補(bǔ)體成分3a(C3a)與連接于固相載體上的抗體結(jié)合,然后加入生物素化的補(bǔ)體成分3a(C3a)抗體,將未結(jié)合的生物素化抗體洗凈后,加入HRP標(biāo)記的親和素,再次徹底洗滌后加入TMB底物顯色。TMB在過氧化物酶的催化下轉(zhuǎn)化成藍(lán)色,并在酸的作用下轉(zhuǎn)化成最終的黃色。顏色的深淺和樣品中的補(bǔ)體成分3a(C3a)呈正相關(guān)。用酶標(biāo)儀在450nm波長下測定吸光度(O.D.值),計(jì)算樣品濃度。

相關(guān)產(chǎn)品

編號 適用物種:Homo sapiens (Human,人) 應(yīng)用(僅供研究使用,不用于臨床診斷!)
RPA387Hu01 補(bǔ)體成分3a(C3a)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
APA387Hu01 補(bǔ)體成分3a(C3a)活性蛋白 Cell?culture;?Activity?Assays.
PAA387Hu01 補(bǔ)體成分3a(C3a)多克隆抗體 WB; IHC; ICC; IP.
MAA387Hu27 補(bǔ)體成分3a(C3a)單克隆抗體 WB; IHC; ICC; IP.
MAA387Hu21 補(bǔ)體成分3a(C3a)單克隆抗體 WB; IHC; ICC; IP.
MAA387Hu22 補(bǔ)體成分3a(C3a)單克隆抗體 WB; IHC; ICC; IP.
MAA387Hu23 補(bǔ)體成分3a(C3a)單克隆抗體 WB; IHC; ICC; IP.
MAA387Hu24 補(bǔ)體成分3a(C3a)單克隆抗體 WB; IHC; ICC; IP.
MAA387Hu29 補(bǔ)體成分3a(C3a)單克隆抗體 WB; IHC; ICC; IP.
MAA387Hu25 補(bǔ)體成分3a(C3a)單克隆抗體 WB; IHC; ICC; IP.
SEA387Hu 補(bǔ)體成分3a(C3a)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) Enzyme-linked immunosorbent assay for Antigen Detection.
WEA387Hu 補(bǔ)體成分3a(C3a)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,寬范圍) Enzyme-linked immunosorbent assay for Antigen Detection.
SCA387Hu 補(bǔ)體成分3a(C3a)檢測試劑盒(化學(xué)發(fā)光免疫分析法) Chemiluminescent immunoassay for Antigen Detection.
LMA387Hu 補(bǔ)體成分3a(C3a)等多因子檢測試劑盒(流式熒光發(fā)光法) FLIA Kit for Antigen Detection.
KSA387Hu01 補(bǔ)體成分3a(C3a)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) Main materials for "Do It (ELISA Kit) Yourself".

參考文獻(xiàn)

雜志 參考文獻(xiàn)
22 Immobilization of soluble complement receptor 1 on islets. [ScienceDirect: S0142961211002596]
Journal of Reproductive Immunology Elevated complement factor C5a in maternal and umbilical cord plasma in preeclampsia [PubMed: 23415845]
Journal of Antimicrobial Chemotherapy Efficacy of a synthetic antimicrobial peptidomimetic versus vancomycin in a Staphylococcus epidermidis device-related murine peritonitis model [Pubmed: 23645587]
SpringerPlus Therapeutic effects of sesame oil on monosodium urate crystal-induced acute inflammatory response in rats [Pubmed: 24353977]
Gynecol Obstet Invest Complement Split Products C3a/C5a and Receptors: Are They Regulated by Circulating Angiotensin II Type 1 Receptor Autoantibody in Severe Preeclampsia? [PubMed: 26485247]
Am J Reprod Immunol Human IgG Antinuclear Antibodies Induce Pregnancy Loss in Mice by Increasing Immune Complex Deposition in Placental Tissue: In Vivo Study [PubMed: 26388133]
Journal of Neuroimmunology Acute and prolonged complement activation in the central nervous system during herpes simplex encephalitis [Pubmed:27235358]
Plos One Alternative Pathway Inhibition by Exogenous Factor H Fails to Attenuate Inflammation and Vascular Leakage in Experimental Pneumococcal Sepsis in Mice [Pubmed:26872035]
Digital Repository Dosagem de fra??es ativadas do sistema complemento em empiema induzido em ratos [10183]
Colloids Surf B Biointerfaces. Interaction of gold and silver nanoparticles with human plasma: Analysis of protein corona reveals specific binding patterns. [pubmed:28131092]
Pediatric Pulmonology Accuracy of complement activation product levels to detect infected pleural effusion in rats [pubmed:28474458]
Journal of Immunology The Complement C3a–C3aR Axis Promotes Development of Thoracic Aortic Dissection via Regulation of MMP2 Expression [Pubmed:29367209]
Artificial?Cells?Nanomedicine and Biotechnology Journal Long term safety and immunological effects of a nanobiotherapeutic, bovine poly-[hemoglobin-catalase-superoxide dismutase-carbonic anhydrase], after four weekly?… [Pubmed:29873524]
Cytotherapy Mesenchymal stromal cell secretory factors induce sustained improvements in islet function pre-and post-transplantation [Doi: 10.1016/j.jcyt.2018.07.007]
Journal of?NeuroVirology Intrathecal complement activation by the classical pathway in tick-borne encephalitis [Pubmed: 30850976]
Clinical Immunology Pathogenic roles of anti-C1q antibodies in recurrent pregnancy loss []
Materials Science and Engineering: C Hemocompatibility of biodegradable Zn-0.8 wt%(Cu, Mn, Li) alloys []
Nanomedicine Complement-mediated hypersensitivity reactions to an amphotericin B-containing lipid complex (Abelcet) in pediatric patients and anesthetized rats: Benefits of slow infusion [33549818]
EXPERIMENTAL EYE RESEARCH Increased ratios of complement factors C3a to C3 in aqueous humor and serum mark glaucoma progression [33493474]
FASEB J C‐reactive protein inhibits C3a/C3aR‐dependent podocyte autophagy in favor of diabetic kidney disease [Pubmed:35503088]
留言咨詢
阳原县| 定兴县| 龙口市| 江安县| 江都市| 易门县| 玉屏| 东乌| 科技| 德惠市| 寿光市| 托克逊县| 安岳县| 太仆寺旗| 类乌齐县| 社旗县| 诸城市| 榕江县| 奈曼旗| 四会市| 青州市| 乌恰县| 肇庆市| 冀州市| 武冈市| 新营市| 钟山县| 香港| 广昌县| 措勤县| 漳浦县| 禹州市| 石门县| 安丘市| 肇庆市| 毕节市| 谷城县| 怀仁县| 当雄县| 石城县| 隆德县|